FORGOTTEN HISTORY: Mydecine - The Untold Story

Northern American researchers sign deal to trial psychedelic medicines in London

North American drug developers have signed a deal with a British company to trial the therapeutic benefits of psychedelic medicines in London.

Evening Standard · Dec 12, 2022

Two Psychedelic Companies File Patent Applications For Psilocybin And MDMA Analogues, Here's What Could Change

Mydecine (OTC: MYCOF) and Lobe Sciences (OTCQB: LOBEF), two companies in the psychedelics space, have filed patent applications.

Benzinga · Jul 19, 2022

Government-Funded Smoking Cessation Trial Uses Mydecine's New Psilocybin-Derived MYCO-001, Recently FDA-Approved

Biotech company Mydecine Innovations Group (OTC: MYCOF) received FDA approval for their novel proprietary MYCO-001. This is the first clearance of the company’s drug product. 

Benzinga · Jun 17, 2022